NCT02923427

Brief Summary

To compare the effects of i-gel and Laryngeal mask airway Supreme (LMA-Supreme) on ventilation parameters and surgical view during Trendelenburg Position laparoscopic gynecological surgery in cases administered positive pressure ventilation without the use of neuromuscular agents.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 22, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 4, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
2.9 years until next milestone

Results Posted

Study results publicly available

October 8, 2020

Completed
Last Updated

October 27, 2020

Status Verified

October 1, 2020

Enrollment Period

1.8 years

First QC Date

September 22, 2016

Results QC Date

December 21, 2017

Last Update Submit

October 6, 2020

Conditions

Keywords

laryngeal mask Supremei-gellaparoscopic gynecological surgery

Outcome Measures

Primary Outcomes (1)

  • Airway Seal Pressure Values

    This value is important as it indicates the feasibility of positive pressure ventilation and the degree of airway protection from supracuff soiling. It is also used in LMA studies as an index of successful placement.Airway pressures of ≈20 cm H2O are typically required in routine practice.

    At baseline and at 15, 30 and 60 minutes

Secondary Outcomes (7)

  • Visual Quality

    during pneumoperitoneum

  • Gastric Tube Insertion

    following airway device insertion up to 5 minutes

  • Postoperative Pharyngolaryngeal Morbidity

    postoperative first hour and 24th hour

  • Sufficiency of Pneumoperitoneum

    baseline

  • Mean Airway Pressure Values

    At baseline and at 15, 30 and 60 minutes

  • +2 more secondary outcomes

Study Arms (2)

Laryngeal mask Supreme

ACTIVE COMPARATOR

Insertion of the "Laryngeal mask Supreme" and evaluation of its clinical performance

Device: Laryngeal mask Supreme Evaluation

i-gel

EXPERIMENTAL

Insertion of the "i-gel" and evaluation of its clinical performance

Device: i-gel Evaluation

Interventions

Evaluation of clinical performance in terms of Insertion, ventilation and complications

Laryngeal mask Supreme

Evaluation of clinical performance in terms of Insertion,ventilation and complications

i-gel

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists classification group I-II
  • between 18-65 years
  • undergoing elective laparoscopic gynecological surgery

You may not qualify if:

  • Those with any neck or upper respiratory tract pathology
  • Those at risk of gastric content regurgitation/aspiration (previous upper Gastrointestinal system surgery, known hiatus hernia, gastroesophageal reflux, history of peptic ulcers, full stomach, pregnancy)
  • Those with low pulmonary compliance or high airway resistance (chronic pulmonary diseases)
  • Obese patients (BMI \>35)
  • Those with throat pain, dysphagia and dysphonia
  • Those with possible or previous difficult airway
  • Those with operations planned for longer than 4 hours
  • Conversion to laparatomy
  • Neuromuscular blocking agent used

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dokuz Eylül University, School of Medicine, Department of Anesthesiology and Reanimation

Izmir, 35340, Turkey (Türkiye)

Location

Results Point of Contact

Title
Anaesthesiology and Intensive Care, Sule Ozbilgin
Organization
DorkuzEU

Study Officials

  • Ferim Günenç, MD

    Dokuz Eylül University, School of Medicine, Department of Anesthesiology and Reanimation

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dokuz Eylul University, MD, Anesthesiologists.

Study Record Dates

First Submitted

September 22, 2016

First Posted

October 4, 2016

Study Start

November 1, 2015

Primary Completion

September 1, 2017

Study Completion

November 1, 2017

Last Updated

October 27, 2020

Results First Posted

October 8, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will share

Locations